Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00199953 · ClinicalTrials.gov registry record · Phase 2
Post-nasal Drainage as an Extraesophageal Manifestation of Reflux
A Phase 2 study, sponsored by Medical College of Wisconsin.
- Completed
- Registry status
- Phase 2
- Development phase
- 50
- Enrollment target
NCT00199953 is a Phase 2 study that has completed, run by Medical College of Wisconsin. The registered enrollment target is 50 participants.
The verdict
NCT00199953, a Phase 2 study, has completed, sponsored by Medical College of Wisconsin.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 50 participants
- Enrollment target
Study Summary
Objectives of this study are: * To quantitatively evaluate the relationship between extraesophageal manifestations of gastroesophageal reflux (EER) and postnasal drainage(PND)in a group of patients without radiographic or endoscopic evidence of sinonasal inflammatory disease. * To assess the efficacy of BID proton pump inhibitors (PPI) in the management of patients with symptomatic postnasal drainage.
Interventions
- DRUG Rabeprazole 20 mg twice a day for 90-day period treatment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2002-06 |
| Est. Completion | 2007-12 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00199953
The ClinicalTrials.gov registry entry for NCT00199953 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medical College of Wisconsin, which has 447 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Rabeprazole 20 mg twice a day for 90-day period treatment is the first listed.
NCT00199953 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00199953 about?
NCT00199953 is a clinical study titled "Post-nasal Drainage as an Extraesophageal Manifestation of Reflux". Objectives of this study are: * To quantitatively evaluate the relationship between extraesophageal manifestations of gastroesophageal reflux (EER) and postnasal drainage(PND)in a group of patients without radiographic or endoscopic evidence of sinonasal inflammatory disease. * To assess the effica...
What is the current status of trial NCT00199953?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 50 participants. The study started on 2002-06. Estimated completion is 2007-12.
What interventions are being tested in trial NCT00199953?
The interventions under investigation include: Rabeprazole 20 mg twice a day for 90-day period treatment (DRUG).
Who is sponsoring clinical trial NCT00199953?
This trial is sponsored by Medical College of Wisconsin, which has 447 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.